332015-13-1 Usage
Uses
Used in Organic Synthesis:
[N-(4-Fluoro-2-nitrophenyl)]3,4,5-trimethoxybenzylamide is utilized as an intermediate in organic synthesis due to its distinctive structural features. Its versatile chemical properties allow for further functionalization and modification, contributing to the development of novel compounds with potential applications in various fields.
Used in Medicinal Chemistry Research:
[N-(4-Fluoro-2-nitrophenyl)]3,4,5-trimethoxybenzylamide serves as a promising candidate in medicinal chemistry research, given its potential pharmaceutical applications. Its structural and chemical properties make it an attractive target for drug development efforts, as it may exhibit biological activity and therapeutic potential. However, further studies are required to ascertain its specific activities and potential therapeutic uses.
Used in Drug Development:
[N-(4-Fluoro-2-nitrophenyl)]3,4,5-trimethoxybenzylamide's unique structure and potential pharmaceutical applications position it as a valuable asset in drug development. Researchers can leverage its properties to design and synthesize new drugs targeting various medical conditions. [N-(4-Fluoro-2-nitrophenyl)]3,4,5-trimethoxybenzylamide's potential as a drug candidate warrants further investigation into its efficacy, safety, and mechanism of action.
Check Digit Verification of cas no
The CAS Registry Mumber 332015-13-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,2,0,1 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 332015-13:
(8*3)+(7*3)+(6*2)+(5*0)+(4*1)+(3*5)+(2*1)+(1*3)=81
81 % 10 = 1
So 332015-13-1 is a valid CAS Registry Number.
332015-13-1Relevant academic research and scientific papers
Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-ones
-
, (2008/06/13)
A method for inhibiting neoplastic cells and related conditions by exposing them to N,N′-substituted benzimidazol-2-ones.
Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
-
, (2008/06/13)
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions, by exposing the affected cells to substituted 2-aryl-benzimidazoles.
